New Horizon seals high price for $263m HK IPO
New Horizon Health, a medical device manufacturer, has scooped up HK$2.04bn ($263.4m) from its IPO after strong institutional investor demand pushed pricing up to the top of the marketed range.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: